Healthy Skepticism Library item: 5422
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Fitzgerald GA.
Coxibs and cardiovascular disease.
N Engl J Med 2004 Oct 21; 351:(17):1709-11
http://content.nejm.org/cgi/content/extract/351/17/1709
Keywords:
Adverse Drug Reaction Reporting Systems
Anti-Inflammatory Agents, Non-Steroidal/adverse effects
Anti-Inflammatory Agents, Non-Steroidal/pharmacology
Cardiovascular Diseases/chemically induced*
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors/adverse effects*
Cyclooxygenase Inhibitors/pharmacology
Drug Approval*
Drug Industry
Epoprostenol/antagonists & inhibitors
Gastrointestinal Diseases/chemically induced
Humans
Isoenzymes/antagonists & inhibitors
Isoenzymes/metabolism
Isoxazoles/adverse effects
Lactones/adverse effects*
Lactones/pharmacology
Membrane Proteins
Naproxen/adverse effects
Prostaglandin-Endoperoxide Synthases/metabolism
Pyrazoles
Risk
Sulfonamides/adverse effects
Sulfonamides/pharmacology
Sulfones
Thromboxane A2/biosynthesis
United States
United States Food and Drug Administration
